Interestingly, ETS factors have been shown to markedly enhance the chromatin occupancy of androgen receptor and reprogram its cistrome in prostate cancer cells [44], resembling the effect of hypoSUMOylation on GR cistrome in B-ALL cells. The gene discussed is NR3C1; the disease is prostate carcinoma.